Acer therapeutics to participate in 2022 bio ceo & investor conference

Newton, mass., feb. 01, 2022 (globe newswire) -- acer therapeutics inc. (nasdaq: acer), a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that acer's management team will virtually participate in the bio ceo & investor conference on february 14-17, 2022.
ACER Ratings Summary
ACER Quant Ranking